SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-033274
Filing Date
2021-08-17
Accepted
2021-08-17 17:20:46
Documents
2
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1624
2 EX-24 DOCUMENT attachment1.htm EX-24 4500
  Complete submission text file 0000899243-21-033274.txt   7717
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O YUMANITY, INC. 40 GUEST STREET, SUITE 4410 BOSTON MA 02135
Business Address
Wyzga Michael D (Reporting) CIK: 0001877600 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 211184019